Details of the Drug

General Information of Drug (ID: DM2EJM3)

• Drug Name: AKB-6548

Indication

Disease Entry	ICD 11	Status	REF
Anaemia	3A90	Phase 3	[1]

• Affected Organisms: Humans and other mammals
• #Ro5 Violations (Lipinski): 0:
  Molecular Weight (mw); 306.7
  Logarithm of the Partition Coefficient (xlogp); 2.5
  Rotatable Bond Count (rotbonds); 4
  Hydrogen Bond Donor Count (hbonddonor); 3
  Hydrogen Bond Acceptor Count (hbondacc); 5
• Chemical Identifiers:
  Formula: C14H11ClN2O4
  IUPAC Name: 2-[[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino]acetic acid
  Canonical SMILES: C1=CC(=CC(=C1)Cl)C2=CC(=C(N=C2)C(=O)NCC(=O)O)O
  InChI: InChI=1S/C14H11ClN2O4/c15-10-3-1-2-8(4-10)9-5-11(18)13(16-6-9)14(21)17-7-12(19)20/h1-6,18H,7H2,(H,17,21)(H,19,20)
  InChIKey: JGRXMPYUTJLTKT-UHFFFAOYSA-N
• Cross-matching ID:
  PubChem CID: 23634441
  ChEBI ID: CHEMBL3646221
  CAS Number: 1000025-07-9
  UNII: I60W9520VV
  DrugBank ID: DB12255
  TTD ID: D07KEH
• Drug-Molecule Activity Atlas (DMA)NEW: Click to Jump to the Detailed DMA Information of This Drug
• Drug ADMET Endpoint Profile (DAE)NEW: Click to Jump to the Detailed DAE Information of This Drug

Molecular Interaction Atlas of This Drug

Drug Therapeutic Target (DTT)

DTT Name	DTT ID	UniProt ID	MOA	REF
HIF-prolyl hydroxylase (HPH)	TTJQFBG	NOUNIPROTAC	Modulator	[2]

Molecular Expression Atlas of This Drug

• The Studied Disease: Anaemia
• ICD Disease Classification: 3A90

Molecule Name	Molecule Type	Gene Name	p-value	Fold-Change	Z-score
HIF-prolyl hydroxylase (HPH)	DTT	NO-GeName	7.70E-01	4.40E-03	0.02

References

• [1] ClinicalTrials.gov (NCT03242967) Study to Evaluate Three Times Per Week (TIW) Oral Dosing of Vadadustat for Anemia in Subjects With Dialysis-Dependent Chronic Kidney Disease (DD-CKD) (TRILOGY). U.S. National Institutes of Health.
• [2] DOI: 10.1038/nrd4422